This topic contains a solution. Click here to go to the answer

Author Question: In the short run, a perfectly competitive firm suffering a loss a. will close if P < AVC b. ... (Read 49 times)

sam.t96

  • Hero Member
  • *****
  • Posts: 570
In the short run, a perfectly competitive firm suffering a loss
 a. will close if P < AVC
  b. will shut down operations if P < MC
  c. cannot leave the industry even if P < AVC
  d. can sell off all its resources to competitors
  e. can raise the price to increase revenues

Question 2

For a nondiscriminating monopolist, which of the following statements is true?
 a. Unlike a firm in perfect competition, a monopolist produces where MR > MC.
  b. The monopolist's marginal revenue curve is the same as its demand curve.
  c. The monopolist will always produce in the inelastic range of its demand curve.
  d. The monopolist does not have a supply curve.
  e. The monopolist produces where MR < MC.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

al

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

A

Answer to Question 2

D




sam.t96

  • Member
  • Posts: 570
Reply 2 on: Jun 30, 2018
Great answer, keep it coming :)


LegendaryAnswers

  • Member
  • Posts: 341
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library